To The Moon

$SPDR S&P Biotech ETF ( $Spdr S&P Biotech Etf(XBI)$ )$ $Pfizer ( $Pfizer(PFE)$ )$ $S&P 500(. $S&P 500(.SPX)$ )$ $Dow Jones Industrial Average(. $Dow Jones(.DJI)$ )$As of April 18, 2025, the U.S. stock market is reeling from a volatile week, with the S&P 500 shedding 2.8% on April 17 and the Dow Jones Industrial Average dropping 1,200 points in a single session. Fears of escalating trade tensions and a hawkish Federal Reserve have sparked widespread selling. Yet, amid the chaos, biotech stocks are staging an unexpected rally, driven by breakthrough drug approvals and M&A chatter. Is this a sector to

What: The electric vehicle (EV) industry is experiencing a rapid transformation as global demand for sustainable transportation increases. With governments pushing for cleaner energy solutions and consumers becoming more environmentally conscious, EV adoption is gaining momentum. This shift is reshaping the automotive sector and influencing stock market trends. Why: The transition to electric vehicles is driven by several factors: Environmental impact: Reducing carbon emissions is a primary motivation, with EVs offering a cleaner alternative to traditional internal combustion engine vehicles. Government policies: Many countries are introducing policies and incentives to support EV adoption, such as subsidies and carbon tax benefits. Technological advancements: Battery technology and chargi

Apple’s Growing China Dilemma Apple’s( $Apple(AAPL)$ ) market cap, currently sitting above $2 trillion, is being tested as geopolitical tensions and regulatory crackdowns in China intensify. Reports reveal slowing iPhone 15 sales in China, Apple’s second-largest market, as local competitors like Huawei gain ground. Simultaneously, Chinese regulators are rumored to be pushing state-owned enterprises to replace foreign tech, including Apple products, with local alternatives. Despite this, Apple has maintained robust growth, and analysts remain divided: Will Apple sustain its $2 trillion valuation, or is a significant correction imminent? Key Metrics: Apple’s China Exposure Bull vs. Bear Case for Apple Amid Challenges Bullish Case Apple’s ecosystem

Cisco closed fiscal 2027's first quarter after the US close on November 12 with the cleanest answer yet to the question that has hung over the stock for a decade: what happens when the company that largely missed the cloud buildout finally gets its turn in the AI one? Revenue came in at $18.52 billion, up 24% year on year — the fastest growth in roughly fifteen years — and adjusted EPS of $1.40 beat the $1.33 consensus by seven cents. The stock closed the regular session up 1.24% at $102.01 and added as much as 8% in extended trading. But the most interesting number was not the beat. Adjusted gross margin fell 2.5 points year on year to 65.6%, while adjusted operating margin hit a record 37.8%. Cisco is buying its way into the AI cycle with gross margin and getting paid back in operating l

Applied Materials, the largest US maker of chipmaking equipment, reported fiscal Q4 2026 after Thursday's close with revenue of $10.41 billion, up 53% year on year, adjusted EPS of $4.16 against $4.06 expected, and a first-quarter guide built around $11.1 billion against $10.87 billion of consensus (Applied Materials Q4 FY26 results, 12 November 2026; Cailian Press, 13 November). Every line beat. The stock, which had already closed down 3.58% at $380.95 before the print, ticked up only about 3% after hours (Sina Finance, 13 November) — a shrug, not a party. That muted reaction is the story. This piece answers one question: when a record year stops moving a stock, what is actually being priced? Figure 1 — The four numbers that define the quarter: revenue, EPS, full-year record, and the guid

CoreWeave, the AI-cloud operator, reported third-quarter revenue of $3.66 billion, up 168% year on year, after the close on November 10 and raised its full-year guidance. That was the headline. The trade landed one session later and one step down the supply chain: on November 11 the optical and interconnect cohort — Applied Optoelectronics, Lumentum, Marvell, Coherent, Corning and Astera Labs — closed up between 6.8% and 15.6%, roughly double the Philadelphia Semiconductor Index's 5.66% gain. The question this piece answers: did optical stocks just reprice funded capex — or a financing mechanic that has not actually closed yet? Figure 1 — CoreWeave's Q3 at a glance: revenue, backlog, the raised full-year revenue guide and the newly priced quarterly interest bill. Sources: CoreWeave Q3 FY26

Nvidia closed Wednesday at $173.73, up 2.87%, on a day the Philadelphia Semiconductor Index rose 5.66% — the biggest one-day rally in the sector in a month. That made the group's largest company its weakest large-cap performer. Two hours later, the same shares were trading near $161, down 7.33% after hours, after The Wall Street Journal reported the board was preparing to meet as soon as Wednesday to discuss CEO Jensen Huang's position. Nothing in the order book changed between the two prints. So which of Wednesday's two prices is the company? Figure 1 — One ticker, two verdicts in a single session. Sources: Xinhua close recap; Investing.com after-hours tracking; Sina Finance. The rally Nvidia sat out The trigger was CoreWeave's third-quarter print — unambiguously a demand signal. Revenue

Nebius Group reports third-quarter results before the US open on November 12, and consensus has already fixed the number: $916.8 million of revenue and a loss of $0.61 a share, per Zacks estimates compiled by EBC Financial Group. The stock traded at $141.45 on November 11, roughly 48% below its October high, according to OpenBell and Zhitong Finance. The question this piece answers is not whether Nebius clears $917 million. It is whether a beat still means anything when the company's own full-year guidance demands a fourth quarter of $1.10 billion to $1.50 billion — a step-up no single print can pre-pay. Figure 1 — The four numbers that frame the print: consensus, the Q4 bridge, the capex plan, and the drawdown. Sources: Zacks via EBC Financial Group, 11 Nov 2026; Nebius Q2 2026 shareholde

Rigetti Computing $Rigetti Computing(RGTI)$ reported third-quarter 2026 revenue of USD 1.411 million after the US close on November 10 — down 27.5% year over year, down 72.5% sequentially, and roughly 60% below the USD 3.52 million consensus. In the same quarter its Cepheus-1-108Q system hit a 99.5% median two-qubit gate fidelity, exactly the target management had set. The stock closed at USD 12.15, off 6.4%, then fell further after hours. Management reiterated a full-year target of about USD 20 million, which now depends on one customer in India passing an acceptance test before December 31. The question is not why revenue missed. It is what a USD 4.1 billion market capitalisation owns when the rest of the year is a single purchase order. Figure

Anthropic launched its roadshow on 10 November with 825 million Class A shares at $70 to $78, a Nasdaq listing under the ticker ANT, and a base raise of $57.75 billion to $64.35 billion before a greenshoe of up to 123.75 million shares (CNR; China Securities Journal). At the top of the range the fully diluted valuation is $1.405 trillion (Securities Times). It is the largest US tech listing since SpaceX raised roughly $85 billion in June — and the first where the company's own suppliers are also its anchor investors. Seven of them signed a $26 billion private placement at the IPO price: Alphabet, Microsoft, Nvidia, AMD, Broadcom, Micron and TSMC (Reuters). The question is not whether the deal clears. It is who carries the risk once the AI financing loop is printed in a public filing — and

$CoreWeave, Inc.(CRWV)$ reports Q3 2026 after Tuesday's close, and the Street will price the print off revenue: consensus sits near $3.54 billion, up roughly 159% year on year. That headline is almost irrelevant. The number that decides this company's fate is the interest bill — guided to $860-940 million for the quarter, up from $640 million last quarter and $267 million four quarters ago. CoreWeave is the largest pure-play renter of $NVIDIA(NVDA)$ GPUs, and it finances every one of them. Tonight's question is not whether the backlog grows. It is whether operating profit grows at least as fast as the interest expense. At the guidance midpoint, the answer is no — by a factor of more than two. Figure 1 — T

Rocket Lab reported its best quarter as a public company on Monday night — record revenue of $267.8 million, up 73% year on year, a record $3.57 billion backlog, and its first positive GAAP operating cash flow of $7.2 million. It also posted a net loss of $79.7 million, more than four times the $18.3 million loss of a year earlier, and confirmed that Neutron, its flagship rocket, will not fly before 2027. $Rocket Lab USA, Inc.(RKLB)$ closed Monday up 10.91% at $58.86, then fell in after-hours trading and quoted about 5.6% lower in Tuesday's pre-market at $55.55 (Seeking Alpha). The question this piece answers: is Rocket Lab a 2026 financial story or a 2027 launch-window story, and which one does today's price actually pay for? Figure 1 — The quart

Advanced Micro Devices just reported the best quarter in its history — $13.4 billion of revenue, up 45% year on year — and the market sold it down 17.26% two days later anyway, then handed every cent back, closing Monday at $508.58, up 13.26%, on Oppenheimer's upgrade. That whiplash is the tell. Data center is now 64% of revenue, gaming is in a 40% collapse, and the valuation — 101 times trailing earnings — rests entirely on whether 2027 supply shows up. What is $Advanced Micro Devices(AMD)$ priced on? Figure 1 — The quarter's four headline numbers: record revenue, the data center doubling, the Q4 guide, the 101x multiple. Sources: AMD Q3 FY26 results, 3 Nov 2026; AMD Form 10-Q, 4 Nov 2026; FinanceFeeds; 36Kr via Robot Belt. The Market Voted Twice